286 related articles for article (PubMed ID: 34484186)
1. Increased IL-23R
Izati AF; Mohd Shukri ND; Wan Ghazali WS; Che Hussin CM; Wong KK
Front Immunol; 2021; 12():690908. PubMed ID: 34484186
[TBL] [Abstract][Full Text] [Related]
2. Increased interleukin-23 receptor(+) T cells in peripheral blood mononuclear cells of patients with systemic lupus erythematosus.
Puwipirom H; Hirankarn N; Sodsai P; Avihingsanon Y; Wongpiyabovorn J; Palaga T
Arthritis Res Ther; 2010; 12(6):R215. PubMed ID: 21110900
[TBL] [Abstract][Full Text] [Related]
3. Hyperproduction of IL-23 and IL-17 in patients with systemic lupus erythematosus: implications for Th17-mediated inflammation in auto-immunity.
Wong CK; Lit LC; Tam LS; Li EK; Wong PT; Lam CW
Clin Immunol; 2008 Jun; 127(3):385-93. PubMed ID: 18373953
[TBL] [Abstract][Full Text] [Related]
4. CD3
Mohd Shukri ND; Farah Izati A; Wan Ghazali WS; Che Hussin CM; Wong KK
Front Immunol; 2021; 12():675250. PubMed ID: 34149710
[TBL] [Abstract][Full Text] [Related]
5. IL-23 Limits the Production of IL-2 and Promotes Autoimmunity in Lupus.
Dai H; He F; Tsokos GC; Kyttaris VC
J Immunol; 2017 Aug; 199(3):903-910. PubMed ID: 28646040
[TBL] [Abstract][Full Text] [Related]
6. BAFF-R and TACI expression on CD3+ T cells: Interplay among BAFF, APRIL and T helper cytokines profile in systemic lupus erythematosus.
Salazar-Camarena DC; Ortíz-Lazareno P; Marín-Rosales M; Cruz A; Muñoz-Valle F; Tapia-Llanos R; Orozco-Barocio G; Machado-Contreras R; Palafox-Sánchez CA
Cytokine; 2019 Feb; 114():115-127. PubMed ID: 30467093
[TBL] [Abstract][Full Text] [Related]
7. Clinical associations of serum interleukin-17 in systemic lupus erythematosus.
Vincent FB; Northcott M; Hoi A; Mackay F; Morand EF
Arthritis Res Ther; 2013 Aug; 15(4):R97. PubMed ID: 23968496
[TBL] [Abstract][Full Text] [Related]
8. Serum free light chains, interferon-alpha, and interleukins in systemic lupus erythematosus.
Jolly M; Francis S; Aggarwal R; Mikolaitis RA; Niewold TB; Chubinskaya S; Block JA; Scanzello C; Sequeira W
Lupus; 2014 Aug; 23(9):881-8. PubMed ID: 24786785
[TBL] [Abstract][Full Text] [Related]
9. Aberrant expression of regulatory cytokine IL-35 in patients with systemic lupus erythematosus.
Cai Z; Wong CK; Kam NW; Dong J; Jiao D; Chu M; Lam CW; Tam LS
Lupus; 2015 Oct; 24(12):1257-66. PubMed ID: 25966926
[TBL] [Abstract][Full Text] [Related]
10. Serum 25-OH vitamin D level in treatment-naïve systemic lupus erythematosus patients: Relation to disease activity, IL-23 and IL-17.
Shahin D; El-Farahaty RM; Houssen ME; Machaly SA; Sallam M; ElSaid TO; Neseem NO
Lupus; 2017 Aug; 26(9):917-926. PubMed ID: 27927883
[TBL] [Abstract][Full Text] [Related]
11. Role of T helper 17 cells in the pathogenesis of systemic lupus erythematosus.
Abou Ghanima AT; Elolemy GG; Ganeb SS; Abo Elazem AA; Abdelgawad ER
Egypt J Immunol; 2012; 19(2):25-33. PubMed ID: 23885404
[TBL] [Abstract][Full Text] [Related]
12. Th22, but not Th17 might be a good index to predict the tissue involvement of systemic lupus erythematosus.
Yang XY; Wang HY; Zhao XY; Wang LJ; Lv QH; Wang QQ
J Clin Immunol; 2013 May; 33(4):767-74. PubMed ID: 23435610
[TBL] [Abstract][Full Text] [Related]
13. Serum and urine interleukin-17A levels as biomarkers of disease activity in systemic lupus erythematosus.
Nordin F; Shaharir SS; Abdul Wahab A; Mustafar R; Abdul Gafor AH; Mohamed Said MS; Rajalingham S; Shah SA
Int J Rheum Dis; 2019 Aug; 22(8):1419-1426. PubMed ID: 31179646
[TBL] [Abstract][Full Text] [Related]
14. [Role of circulating T follicular helper subsets and T follicular helper effector memory cells in systemic lupus erythematosus].
Liang YC; Yao Y; Zhang RJ; Shao M; Sun XL; Shi GX; Gao C; Yu D; He J
Zhonghua Yi Xue Za Zhi; 2019 Jan; 99(3):164-168. PubMed ID: 30669756
[No Abstract] [Full Text] [Related]
15. Changes of Serum IL-6, IL-17, and Complements in Systemic Lupus Erythematosus Patients.
Tang Y; Tao H; Gong Y; Chen F; Li C; Yang X
J Interferon Cytokine Res; 2019 Jul; 39(7):410-415. PubMed ID: 31173544
[TBL] [Abstract][Full Text] [Related]
16. The model of circulating immune complexes and interleukin-6 improves the prediction of disease activity in systemic lupus erythematosus.
Thanadetsuntorn C; Ngamjanyaporn P; Setthaudom C; Hodge K; Saengpiya N; Pisitkun P
Sci Rep; 2018 Feb; 8(1):2620. PubMed ID: 29422675
[TBL] [Abstract][Full Text] [Related]
17. Antibodies against High Mobility Group Box protein-1 (HMGB1) versus other anti-nuclear antibody fine-specificities and disease activity in systemic lupus erythematosus.
Wirestam L; Schierbeck H; Skogh T; Gunnarsson I; Ottosson L; Erlandsson-Harris H; Wetterö J; Sjöwall C
Arthritis Res Ther; 2015 Nov; 17():338. PubMed ID: 26596890
[TBL] [Abstract][Full Text] [Related]
18. Increased serum APRIL differentially correlates with distinct cytokine profiles and disease activity in systemic lupus erythematosus patients.
Boghdadi G; Elewa EA
Rheumatol Int; 2014 Sep; 34(9):1217-23. PubMed ID: 24748505
[TBL] [Abstract][Full Text] [Related]
19. Interleukin-32γ: Possible association with the activity and development of nephritis in patients with systemic lupus erythematosus.
Kwon OC; Ghang B; Lee EJ; Hong S; Lee CK; Yoo B; Kim S; Kim YG
Int J Rheum Dis; 2019 Jul; 22(7):1305-1311. PubMed ID: 30941928
[TBL] [Abstract][Full Text] [Related]
20. Cytokines, 25-OH vit D and disease activity in patients with juvenile-onset systemic lupus erythematosus.
Abo-Shanab AM; Kholoussi S; Kandil R; Dorgham D
Lupus; 2021 Mar; 30(3):459-464. PubMed ID: 33183127
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
